Mohammad Razaq
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Oncology top 10%
- Lung Cancer Research Studies
Papers in
- Oncology 10
- Cancer Cells and Metastasis 2
-
- Extracellular vesicles in disease 4
- Cancer therapeutics and mechanisms 2
- Circular RNAs in diseases 2
- Co-authors
- Anupama Munshi (4 shared papers)Akhil Srivastava (4 shared papers)Narsireddy Amreddy (4 shared papers)Rajagopal Ramesh (4 shared papers)Meghna Mehta (3 shared papers)Rebaz Ahmed (3 shared papers)Yan D. Zhao (2 shared papers)Mahendran Chinnappan (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)American Journal of Therapeutics (3 papers)Cancer (2 papers)Anticancer Research (2 papers)Scientific Reports (1 paper)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Mohammad Razaq
21 papers receiving 744 citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Cancer Research 227
- Oncology 259
- Otorhinolaryngology 35
- Molecular Biology 372
- Pulmonary and Respiratory Medicine 165
Countries citing papers authored by Mohammad Razaq
This map shows the geographic impact of Mohammad Razaq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Razaq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Razaq more than expected).
Fields of papers citing papers by Mohammad Razaq
This network shows the impact of papers produced by Mohammad Razaq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Razaq. The network helps show where Mohammad Razaq may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Razaq, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 157 | |
| 2 | Phase 1/2a, open‐label, multicenter study of Hit paper breakdown → | 2021 | 120 |
| 3 | 2020 | 95 | |
| 4 | 2020 | 88 | |
| 5 | 2018 | 57 | |
| 6 | 2020 | 48 | |
| 7 | 2020 | 41 | |
| 8 | 2020 | 37 | |
| 9 | 2019 | 23 | |
| 10 | 2018 | 23 | |
| 11 | 2004 | 22 | |
| 12 | 2007 | 15 | |
| 13 | 2018 | 9 | |
| 14 | 2017 | 9 | |
| 15 | 2019 | 4 | |
| 16 | 2019 | 4 | |
| 17 | 2004 | 3 | |
| 18 | 2018 | 2 | |
| 19 | 2021 | 1 | |
| 20 | 2015 | 1 |
About Mohammad Razaq
Mohammad Razaq is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 22 papers that have together received 760 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Extracellular vesicles in disease (4 papers), Salivary Gland Tumors Diagnosis and Treatment (3 papers), Head and Neck Cancer Studies (3 papers), Photodynamic Therapy Research Studies (3 papers), Cancer therapeutics and mechanisms (2 papers), Cancer Cells and Metastasis (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Cancer Research (227 citations), Oncology (259 citations), Otorhinolaryngology (35 citations), Molecular Biology (372 citations) and Pulmonary and Respiratory Medicine (165 citations). Mohammad Razaq has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Anupama Munshi, Akhil Srivastava, Narsireddy Amreddy, Rajagopal Ramesh, Meghna Mehta, Rebaz Ahmed, Yan D. Zhao, Mahendran Chinnappan, Mary J. Fidler and Ann M. Gillenwater. Their work appears in journals such as Journal of Clinical Oncology, American Journal of Therapeutics, Cancer, Anticancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.